• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment.

作者信息

Ma Li-Yangxue, Su Li

机构信息

Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

出版信息

Chin Med J (Engl). 2018 Oct 20;131(20):2510-2513. doi: 10.4103/0366-6999.243567.

DOI:10.4103/0366-6999.243567
PMID:30334543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202603/
Abstract
摘要

相似文献

1
Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment.来那度胺在弥漫性大B细胞淋巴瘤中的应用：挽救治疗、维持治疗及诱导治疗
Chin Med J (Engl). 2018 Oct 20;131(20):2510-2513. doi: 10.4103/0366-6999.243567.
2
Lenalidomide Maintenance after R-CHOP Therapy in Diffuse Large B-Cell Lymphoma: Can It Be a Standard of Care.来那度胺用于弥漫性大B细胞淋巴瘤R-CHOP治疗后的维持治疗：它能否成为标准治疗方案？
Acta Haematol. 2017;138(4):216-220. doi: 10.1159/000484515. Epub 2017 Dec 7.
3
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.来那度胺维持治疗不适用于自体干细胞移植的复发弥漫性大B细胞淋巴瘤患者：一项开放标签、单臂、多中心2期试验。
Lancet Haematol. 2017 Mar;4(3):e137-e146. doi: 10.1016/S2352-3026(17)30016-9. Epub 2017 Feb 17.
4
Rituximab-lenalidomide-dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma.利妥昔单抗-来那度胺-地塞米松可诱导复发难治性弥漫性大B细胞非霍奇金淋巴瘤实现完全且持久的缓解。
Leuk Lymphoma. 2010 Sep;51(9):1758-60. doi: 10.3109/10428194.2010.497886.
5
Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab.来那度胺联合利妥昔单抗治疗老年复发弥漫性大B细胞淋巴瘤患者的长期无病生存
Haematologica. 2016 Sep;101(9):e385-6. doi: 10.3324/haematol.2016.147256. Epub 2016 May 31.
6
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.来那度胺联合 R-CHOP 克服了新诊断弥漫性大 B 细胞淋巴瘤中非生发中心 B 细胞表型的不良预后影响：一项 II 期研究。
J Clin Oncol. 2015 Jan 20;33(3):251-7. doi: 10.1200/JCO.2014.55.5714. Epub 2014 Aug 18.
7
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.来那度胺联合R-ESHAP方案治疗复发或难治性弥漫性大B细胞淋巴瘤患者：GELTAMO组的1b期研究
Br J Haematol. 2016 Apr;173(2):245-52. doi: 10.1111/bjh.13945. Epub 2016 Feb 5.
8
Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.利妥昔单抗、来那度胺和伊布替尼用于复发/难治性原发性皮肤弥漫性大B细胞淋巴瘤，腿部型
Br J Haematol. 2022 Feb;196(4):e30-e33. doi: 10.1111/bjh.17886. Epub 2021 Oct 12.
9
Lenalidomide for the treatment of B-cell lymphoma.来那度胺用于治疗B细胞淋巴瘤。
Expert Opin Investig Drugs. 2016 Sep;25(9):1103-16. doi: 10.1080/13543784.2016.1208170. Epub 2016 Jul 22.
10
The evolving role of lenalidomide in non-Hodgkin lymphoma.来那度胺在非霍奇金淋巴瘤中不断演变的作用。
Leuk Lymphoma. 2016 Jul;57(7):1507-16. doi: 10.3109/10428194.2016.1146949. Epub 2016 Feb 22.

引用本文的文献

1
Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis.来那度胺单药治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效与安全性：系统评价和荟萃分析
Front Oncol. 2021 Dec 2;11:756728. doi: 10.3389/fonc.2021.756728. eCollection 2021.
2
Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma.人工气胸无关性脓胸相关淋巴瘤的特征描述
J Oncol. 2021 Jan 25;2021:3869438. doi: 10.1155/2021/3869438. eCollection 2021.

本文引用的文献

1
Maintenance therapy following induction chemoimmunotherapy in patients with diffuse large B-cell lymphoma: current perspective.弥漫性大 B 细胞淋巴瘤患者诱导化疗免疫治疗后的维持治疗：当前观点。
Ann Oncol. 2017 Nov 1;28(11):2680-2690. doi: 10.1093/annonc/mdx358.
2
Lenalidomide modulates gene expression in human ABC-DLBCL cells by regulating IKAROS interaction with an intronic control region of SPIB.来那度胺通过调节IKAROS与SPIB内含子控制区域的相互作用来调节人ABC-DLBCL细胞中的基因表达。
Exp Hematol. 2017 Dec;56:46-57.e1. doi: 10.1016/j.exphem.2017.09.002. Epub 2017 Sep 8.
3
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.来那度胺维持治疗对比安慰剂用于一线利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松治疗的老年弥漫性大 B 细胞淋巴瘤患者。
J Clin Oncol. 2017 Aug 1;35(22):2473-2481. doi: 10.1200/JCO.2017.72.6984. Epub 2017 Apr 20.
4
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.一项2/3期多中心、随机、开放标签研究，比较来那度胺与研究者选择的方案对复发或难治性弥漫性大B细胞淋巴瘤患者的疗效和安全性。
Clin Cancer Res. 2017 Aug 1;23(15):4127-4137. doi: 10.1158/1078-0432.CCR-16-2818. Epub 2017 Apr 5.
5
Lenalidomide for the treatment of B-cell lymphoma.来那度胺用于治疗B细胞淋巴瘤。
Expert Opin Investig Drugs. 2016 Sep;25(9):1103-16. doi: 10.1080/13543784.2016.1208170. Epub 2016 Jul 22.
6
Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab.来那度胺联合利妥昔单抗治疗老年复发弥漫性大B细胞淋巴瘤患者的长期无病生存
Haematologica. 2016 Sep;101(9):e385-6. doi: 10.3324/haematol.2016.147256. Epub 2016 May 31.
7
ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.稳健性：来那度胺-R-CHOP方案与安慰剂-R-CHOP方案治疗既往未治疗的ABC型弥漫性大B细胞淋巴瘤的对比
Future Oncol. 2016 Jul;12(13):1553-63. doi: 10.2217/fon-2016-0130. Epub 2016 Apr 18.
8
The novel mechanism of lenalidomide activity.来那度胺活性的新机制。
Blood. 2015 Nov 19;126(21):2366-9. doi: 10.1182/blood-2015-07-567958. Epub 2015 Oct 5.
9
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice.来那度胺单药治疗难治性非霍奇金淋巴瘤患者：意大利一项日常临床实践中的多中心观察性回顾性研究
Leuk Lymphoma. 2015 Jun;56(6):1671-6. doi: 10.3109/10428194.2014.964702. Epub 2014 Nov 19.
10
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.来那度胺联合 R-CHOP 克服了新诊断弥漫性大 B 细胞淋巴瘤中非生发中心 B 细胞表型的不良预后影响：一项 II 期研究。
J Clin Oncol. 2015 Jan 20;33(3):251-7. doi: 10.1200/JCO.2014.55.5714. Epub 2014 Aug 18.